Webinars and podcasts
Webinars and podcasts are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
This webinar summarises the clinical and research landscape for CAR-T and T-cell engaging antibody therapies and show how single domain VHH antibodies can be applied to optimise the next generation of these important new therapeutic modalities.
This webinar covers the unique characteristics of VHH, including high stability, comparable affinity to standard IgGs and their flexibility in terms of generating multi-specific therapeutics. These properties, combined with Isogenica’s humanised, CMC-liability free VHH libraries allows us to generate novel multi-specifics at unmatched speed and quality.